Encarnación-Navarro, Juan-Antonio; López-Jiménez, Enrique; Alonso-Romero, José-Luis; Ruiz-Carreño, Paula; Ros-Martínez, Silverio; de-la-Fuente-Muñoz, Isabel; López, Francisco; Cárdenas-Cánovas, Enrique; Laborda-Segovia, Ana; Sánchez-Pérez, Marta; Rodríguez, Cristina; Mansó-Murcia, Clara; Ortega-López, Nicolás-Darío; López-Cubillana, Pedro; Guzmán-Martínez-Valls, Pablo-Luis; Cao-Avellaneda, Enrique; López-González, Pedro-Ángel; López-Abad, Alicia
(MDPI, 2025-12-13)
BACKGROUND: Androgen deprivation therapy (ADT) is a fundamental component of treatment for metastatic hormone-sensitive prostate cancer (mHSPC), but it accelerates bone mineral density loss and increases fracture risk. ...